Almost a decade since sharps legislation was passed in Europe and the US, compliance still has a way to go to reach mandatory legal requirements in hospitals - and even more so in non-hospital locations.
To understand future demand for safety syringes, George I’ons, head of product strategy and insights at Owen Mumford examines research into trends and drivers surrounding safety-device take up.
Administration of medication by injection in non-hospital settings is increasingly becoming more of a norm in the EU and the US. A number of elements are driving this trend, first and foremost the need to reduce the burden on pressurised hospitals to provide treatment for chronic diseases that often require daily, typically subcutaneous, injection.
With more and more people administering treatment themselves in their home each day, or receiving treatment from carers and visiting nurses, the issue of needlestick safety during injection has spread far beyond the strictly clinical setting.
Log in or register FREE to read the rest
This story is Premium Content and is only available to registered users. Please log in at the top of the page to view the full text.
If you don't already have an account, please register with us completely free of charge.
